Dopamine-induced programmed cell death in mouse thymocytes  by Offen, Daniel et al.
ELSEVIER Biochimica et Biophysica Acta 1268 (1995) 171 - 177 
Biochi ~mic~a et Biophysica AEta 
Dopamine-induced programmed cell death in mouse thymocytes 
Daniel Offen a, Ilan Ziv a, Svetlana Gorodin a, Ari Barzilai c, Zvi Malik b, Eldad Melamed a,* 
a Department of Neurology and the Felsenstein Medical Research Institute, Beilinson Medical Center, Petah Tiqva, Israel 
b Life Sciences Department, Bar llan University, Ramat Gan, Israel 
c Department of Biochemistry, the George Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel 
Received 5April 1995; accepted 20 April 1995 
Abstract 
Exposure of mouse thymocytes to dopamine caused apoptosis (programmed cell death). This was manifested by cellular condensation 
and membrane damage shown by flow cytometry measurements and scanning electron microscopic study. Dopamine also affected 
thymocytic nuclei and their genomic DNA integrity. Most of the DNA molecules accumulated in a subdiploid peak in flow cytometry 
analysis, indicating DNA fragmentation to small particles. DNA analysis showed the typical pattern of 'DNA ladder' caused by 
internucleosomal DNA cleavage. X-ray microanalysis of the cellular elements of dopamine-treated cells showed elevation of sodium 
(Na), chloride (C1) and calcium (Ca) peaks, accompanied by reduction in phosphate (P) concentrations. Comparison of the potassium (K) 
and P concentrations showed significant differences between the two major death processes: necrosis (induced by exposure to sodium 
azide (NAN3)) and apoptosis (induced by dopamine). High concentrations of K indicated cell viability while reductions in P and 
elevations in Ca levels were found to be typical of apoptotic ell death. The antioxidant dithiothreitol (DTT) suppressed dopamine-in- 
duced apoptosis in thymocytes, uggesting that its toxicity may be mediated via generation of reactive oxygen radicals. Our study 
suggests that under certain circumstances, dopamine and/or its metabolites, may induce a process of apoptotic ell death of the 
dopamine-producing cells in the substantia nigra. Increased accessibility of dopamine to the nigral cell nucleus or inability to scavenge 
excess free radicals generated from dopamine oxidation triggering programmed cell death, may cause the progressive nigral degeneration 
in Parkinson's disease. 
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I. Introduction 
The cause for the rather selective degeneration of the 
substantia nigra pigmented dopaminergic neurons in 
Parkinson's disease is still unknown [1]. Dopamine, the 
natural neurotransmitter in the nigrostriatal projection, has 
potent anticancer properties and is highly toxic to several 
cell lines (e.g., melanoma) in vitro [2]. Auto-and enzymatic 
oxidation of dopamine .generate a variety of cytotoxic 
oxygen radical species [3]. It is theoretically possible that 
nigral cell death in Parkinson's disease is etiologically 
linked to excessive local oxidant stress due to breakdown 
of dopamine, mainly by monoamine oxidase, and linked to 
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presence of high concentrations of iron and synthesis of 
neuromelanin [4]. It was suggested that the formed free 
radicals cause membranal lipid peroxidation and rupture, 
leading to neuronal disintegration [5]. However, nigral 
degeneration i  Parkinson's disease is a protracted 'silent' 
process that lacks the features of necrotic cell death [6]. 
Apoptosis is a death process with distinctive morpho- 
logical characteristics set in motion by activation of a 
dormant nuclear genetic program for cellular self-destruc- 
tion [7]. Many anticancer drugs work by triggering pro- 
grammed cell death [8]. We hypothesized that dopamine 
itself or the reactive oxygen radicals generated uring its 
metabolism ay, under certain circumstances, cause inap- 
propriate activation of apoptosis-like programmed cell 
death in substantia nigra neurons, thus leading to the 
evolution of Parkinson's disease. Thymocytes exposed to 
dexamethasone r present a well-established model for 
apoptosis [9]. We therefore xamined whether dopamine 
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can induce the typical features of programmed cell death 
in mouse thymocytes. 
2. Materials and methods 
2.1. Cell culture 
Thymocytes were obtained from 4-week-old BALB/c 
mice. Animals were sacrificed by cervical dislocation and 
the thymus removed and placed in RPMI 1660 medium. 
The cell suspension was washed and adjusted to a concen- 
tration of 2 x 10 6 cell/ml in RPMI 1660 medium supple- 
mented with 5% fetal calf serum (FCS) and 10 mM Hepes 
buffer. Aliquots of 2 ml thymocytes were incubated at 
either 37°C or 4°C with various drugs (dopamine, dexa- 
methasone and sodium azide). The cells were washed with 
PBS (10 mM sodium phosphate [pH 7.4], 2.5 mM KC1, 
137 mM NaCl) and processed. 
2.2. DNA labeling and f low cytometry analysis 
Thymocytes were washed twice with PBS by centrif- 
ugation for 10 min at 200 X g. Cell pellets were gently 
resuspended in PBS, at a concentration of l06, and the 
forward scatter (FSc) and the side scatter (SSc) were 
simultaneously measured. Cell nuclei were isolated by 
resuspending cell pellets in 1.5 ml hypotonic fluorochrome 
solution containing propidium iodide (PI) 50 ug/ml in 
0.1% sodium citrate plus 0.1% Triton X-100 (Sigma, 
Israel), in 12 X 75 polypropylene tubes (Becton and Dick- 
inson, [BD]). The tubes were placed in the dark overnight 
at 4°C before the flow cytometric analysis. Cell nuclei 
were evaluated for DNA fragmentation by using flow 
cytometry (BD) as described by Nicoletti et al. [11]. Argon 
laser beam (488 riM) was used to excite the PI dye and the 
red fluorescence was collected via a 610 nm long pass 
filter. The data was processed by a Hewlett Packard com- 
puter and analyzed with Lysis software (BD). 
Fig. 1. Flow analysis of dopamine-treated mouse thymocytes. Cells were treated for 3 h at 37°C with dopamine (D,F), dopamine (on line) with 
dithiothreitol (DTT) (C,G) or sodium azide (NAN3) (D,H). Left panels: whole cell analysis for cell size (FSC, forward high scattering) and cell granulation 
(SSC, side high scattering). Right panels: estimate ofDNA content inisolated cell nuclei. 
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2.3. X-ray microanalysis of cells 
X-ray microanalysis (XRMA) for measurement of cellu- 
lar elements, including sodium (Na), phosphate (P), sul- 
phate (S), chloride (C1), potassium (K) and calcium (Ca), 
was performed on mouse thymocytes after 3 h of treatment 
with the various drugs. The cells were rinsed, resuspended 
in PBS and attached to Thermanox (Nunc, Nupervile, IL) 
plastic coverslips which had been previously treated with 
poly-L-lysine (Sigma, Israel). The cell monolayers on the 
coverslips were placed in multiwell dishes filled with 
buffer. The attached cells were quickly rinsed by dipping 
in ammonium acetate 0.15 M (pH 7.0), for 2-3 s. The 
rinsed cells were immediately frozen with liquid nitrogen, 
freeze-dried at -80°C and than coated with a layer of 
carbon [10]. XRAM was performed on 50 cells from each 
sample using an eXL-Link system (Oxford Institute, Ox- 
ford, UK) attached to a Jeol 840 scanning electron micro- 
scope (S.E.M.). 
2.4. DNA analysis 
DNA was isolated from the cells, washed twice with 
PBS and pelleted by centrifugation at200 X g for 5 min at 
room temperature. Cell pellets were resuspended at a 
concentration of 2 X 107 cells/ml in cell lysis buffer (10 
mM EDTA, 10 mM Tris (pH 7.4), 0.25% Triton X-100 
and 50 tzg/ml proteinase K) and incubated for 1 h at 
50°C. RNAse A was then added at a concentration f 0.01 
mg/ml and incubation at 37°C was continued for 1 h. The 
crude DNA preparations 'were then extracted with phenol, 
and (twice) with chloroform/isoamyl alcohol (24:1). The 
DNA was precipitated for 24 h in 2 volumes of ethanol at 
-70°C, and then resuspended in 10 mM Tris-HC1 (pH 
8.0) 1 mM EDTA (TE buffer). Electrophoresis of the 
isolated DNA was carried out in 2% agarose gels. Before 
electrophoresis, loading buffer (10 mM EDTA, 0.25% 
(W/V) bromophenol blue and 50% (V/V) glycerol) was 
added to each sample at a 1:5 ratio. Samples were then 
heated to 65°C for 10 mi:a and plunged into ice. Approxi- 
mately 10 /xg of DNA was loaded into each well and 
electrophoresis was carried out at 6V per cm of gel in TBE 
buffer (2 mM EDTA [pH 8.0], 89 mM Tris, 89 mM boric 
acid). An HealII digest of OX-174 DNA was applied to 
each gel to provide size markers of 1353, 1078, 872, 603, 
310, 281,271, 234, 194, 118 base pair (bp), respectively. 
Scanning electron microscopy (SEM) of thymocytes. 
The cells, fixed with glLutaraldehyde/paraformaldehyde, 
were prepared for SEMI by the triple fixation GTGO 
method [12]. Briefly, cells were post-fixed in 2% OsO 4, 
then fixed again with 2% tannic acid/guanidine, and 
dehydrated in graded ethanol solutions; ethanol was then 
exchanged with graded solutions of Freon 113, and the 
samples were air-dried and gold-coated. The cells were 
examined with a Joel 840 scanning electron microscope; 
200 cells from each sample were visualized for cell mor- 
phology [12]. 
3. Results 
3.1. Flow cytometric pattern of dopamine-treated thymo- 
cytes 
Whole thymocyte cells were first analyzed by light 
scatter flow cytometry. The SSc/FSc that might indicate 
cell size parameter and SSc that serves as a measure for 
cell granularity were determined simultaneously. The un- 
treated control thymocyte population showed a uniform 
pattern with minor differences in cell size (Fig. 1A). 
Exposure of the cells to physiological concentrations of
dopamine (0.3-1 raM) for 3 h caused a significant shift to 
the left, indicating that most of the cells underwent cellular 
condensation. Similar results were observed using dexa- 
methasone which is known to induce apoptosis in the 
model system. In addition to the left shift changes, the cell 
population showed an increased SSc parameter (Fig. 1B). 
The addition of the antioxidant dithiothreitol (DTT) (1 
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Fig. 2. X-ray microanalysis spectra of thymocytes treated with dopamine 
(0.5 mM) in comparison to control, untreated cells. At the end of the 
dopamine treatment, cells were attached to Thermanox coverslips using 
poly-L-lysine, rinsed for 2 s in ammonium acetate, immediately fixed in 
liquid nitrogen, carbon-coated and elemental composition was determined 
by SEM with an X-ray microprobe. Each spectrum was accumulated from 
50 individual cells. 
174 D. Often et aL / Biochimica et Biophysica Acta 1268 (1995) 171-177 
1A 
1.2 
O 1 
~ o~ 
~ O.6 
0.4 
O.2 
1.6 
0 ~.4 
, 
~ ° ,  
f,~ o.6 
~ 0.4 
O2 
0 
Con. Con. DA DA DA ~ NaNS 
4c 37c 0.125¢nM 0.SmM 1ram 1ram 0.1% 
Fig. 3. The K /S  and P/S  molar ratios of thymocytes exposed to 
dopamine, dexamethasone or sodium azide (NAN3). The cells from three 
different experiments were treated as in Fig. 2 and the integrated peak 
ratios obtained from 50 cells were calculated. Data from three different 
experiments are the mean_+S.D. The group data were compared by 
two-tailed t-test ( ~ P < 0.05, * * P < 0.01 as compared to controls 37°C). 
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Fig. 4. DNA analysis of dopamine-treated mouse thymocytes. Cells were 
treated with dopamine, dexamethasone (Dex) or sodium azide (NAN3) as 
indicated. The isolated DNA was analyzed on agarose gel-electrophoresis 
and DNA from phage x174 cut with HaelII was used as a molecular 
weight marker. 
mM) to the dopamine-treated cells inhibited most of the 
observed effects (Fig. 1C). Thymocytes were exposed to 
0.1% sodium azide (NaN 3) for 3 h to provide a model of 
necrotic ell death. Although NaN 3 caused a massive cell 
death, as indicated by trypan blue exclusion assay (data not 
shown), most of the morphological changes seen with 
dopamine were not observed following exposure to this 
drug (Fig. 1D). 
Analysis of the propidium-iodide-stained DNA by flow 
cytometry enabled the estimation of DNA content of iso- 
lated nuclei. In untreated cells, 82% of the measured 
events created a sharp, distinct peak of intact DNA, char- 
acteristic of the diploid form (Fig. 1E). Exposure to 1 mM 
dopamine caused a marked reduction of the DNA content 
in the diploid peak to 8.8% and most of the events created 
a typical 'apoptotic' subdiploid peak (Fig. 1F). Combined 
treatment with DTT (1 mM) provided protection against 
DNA fragmentation with about 40% of the events present 
in the diploid peak (Fig. 1G). In contrast, necrotic cell 
death caused by NaN 3 was  not accompanied by DNA 
fragmentation as there was no accumulation of a sub- 
diploid peak (Fig. 1H). 
3.2. X-ray microanalysis ofthymocytes 
X-ray microanalysis of cells provides an accurate sti- 
mate of the concentrations and the molar ratios of the 
cellular elements, such as K, Na, P, C1, and S [10]. 
Thymocytes, treated by the various drugs, were submitted 
to XRMA. The spectra shown in Fig. 2 represent data 
accumulated from a sample of 50 cells, measured simulta- 
neously. Fig. 2 shows that in dopamine-treated c lls, there 
is a decrease in K and, in parallel, an increase in the levels 
of C1, Na and Ca in comparison to the control cells. These 
results may reflect membranal damage that leads to K 
leakage out of the cells and influx of Na, Ci and Ca influx. 
The S peak is generated mostly by the sulphuric residues 
of cellular proteins. Since the concentration of such pro- 
teins is relatively stable (compared to the ions that can 
easily leak out through the membrane), we used the S peak 
as an internal standard. A decrease in the K /S  molar ratio 
is indicative of cell death [10], while a low P /S  molar 
ratio may reflect DNA breakdown and nucleotide leakage 
out of the cells. 
Fig. 3 shows the molar ratios of K /S  and P /S  obtained 
during the various treatments of the thymocytes. Cells 
Fig. 5. Scanning electron microscopy (SEM) showing the morphological lterations of dopamine-treated thymocytes. Control, untreated cells have 
well-preserved microvilli and some outer membrane ruffles (a), while the dopamine-treated cells are completely smooth or shrunk following exposure to 
0.25 mM dopamine (b). Exposure to higher concentrations of dopamine causes cell shrinkage and membrane disintegration (c). Original magnification 
×5000. 
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treated either by dopamine, dexamethasone or NaN 3 
showed a decrease in total cellular K per cellular protein 
(K/S). These parameters indicate inviability of those cells 
after 3 h of exposure to these drugs. No significant differ- 
ences were measured between dopamine, dexamethasone 
and NaN 3. In contrast, the P /S  molar ratios showed 
marked and significant differences in the dopamine and 
dexamethasone-treated cellsas compared to those treated 
with NaN 3. The similar alterations of the P /S  molar ratios 
in the thymocytes exposed to dopamine and dexametha- 
sone is unique and points to a similar death mechanism 
involving breakage and extracellular leakage of small DNA 
fragments. 
3.3. Dopamine induces DNA fragmentation in thymocytes 
One of the features distinguishing apoptosis from necro- 
sis is the early onset of specific endonuclease-mediated 
cleavage of cellular DNA into nucleosome ladders [13]. 
We therefore xamined whether dopamine can elicit a 
similar pattern of DNA fragmentation in thymocytes. DNA 
analysis of cells exposed to 1 mM dopamine revealed the 
typical DNA cleavage already after 2 h of treatment (Fig. 
4). Since untreated thymocytes may often undergo sponta- 
neous DNA fragmentation during incubation at 37°C both 
temperatures of 4°C and 37°C incubation conditions were 
used as controls. Indeed, some DNA fragmentation was 
seen in untreated cells but it is markedly different from the 
pattern observed following dopamine treatment for 4 or 
even 2 h. The fragments een in Fig. 4 were formed in 
order of sizes, i.e., 180, 360, 540 and 720 bp etc., creating 
the characteristic apoptotic DNA ladder. The similar DNA 
fragmentation pattern seen in cells treated with dopamine 
and dexamethasone i  contrast o NaN 3 suggests that the 
cell death mechanism induced by dopamine is due to 
apoptosis. DTT prevented the dopamine-induced formation 
of the typical apoptotic 'DNA ladder' on agarose gel (data 
not shown), similar to its inhibitory effect on DNA frag- 
mentation seen in the FACS analysis (Fig. 1). 
3.4. Dopamine-induced ultrastructural features of  apop- 
totic death 
Cells undergoing programmed cell death shrink and 
their outer membranes form bullous structures termed blebs 
[14]. SEM of mouse thymocytes treated with dopamine 
showed various cellular alterations (Fig. 5a-c). Exposure 
for 3 h to 0.25 mM dopamine caused marked membranal 
changes. The outer membrane totally disappeared with the 
characteristic formation of blebbing. Fig. 5b shows that 
some of these blebs are detached from the plasma mem- 
brane. Exposure to a higher concentration of dopamine 
(0.5 mM for 3 h) caused the beginning of cell shrinkage 
and marked plasma membrane disintegration (Fig. 5c). 
Thymocytes treated with DEX showed similar apoptotic 
features to those observed following exposure to dopamine. 
Treatment with DTT inhibited the morphological alter- 
ations induced by dopamine (data not shown). 
4. Discussion 
We exposed thymocytes to dopamine, at concentrations 
of 0.1 - 1 mM, similar to the physiological levels within the 
nigral neurons, as shown by Michel and Hefti [4]. Flow 
cytometry measurements on thymocytes treated with 
dopamine (1 mM, for 4 h) demonstrated condensation and 
granulation of whole cells and accumulation of a sub- 
diploid peak of fragmented DNA particles (Fig. 1). DNA 
analysis revealed a distinct laddering pattern of internucle- 
osomal DNA cleavage to discrete fragments, differing in 
size by multiples of about 180 base-pairs (Fig. 4). Further- 
more, electronmicroscopy demonstrated that thymocytes 
exposed to dopamine undergo marked morphological 
changes, including creation of outer membranal blebs (Fig. 
5). These alterations were identical to those caused by 
treatment with dexamethasone, a classical inducer of apop- 
tosis in thymocytes [15]. By contrast, exposure to NaN 3, a 
toxin that typically kills cells by causing necrosis [16], did 
not induce any of the above markers for apoptosis in 
thymocytes. 
We also carried out X-ray microanalysis of dopamine- 
treated and control thymocytes to estimate spectra of vari- 
ous intracellular elements. It was demonstrated that in- 
creased peaks of K, P and CI may provide an index for 
healthy, well-preserved cells [10]. In contrast, we found 
relatively elevated Na, C1 and Ca and reduced P peaks in 
thymocytes exposed to dopamine (Fig. 2). Such alterations 
in concentrations of the ions are generally indicative of 
membranal damage [17]. The increased K concentration 
might be a result of inactivation of the K leak-out channels 
[18], while elevated levels of Na and C1 might reflect 
dysfunction of the Na +/K  + ATPase [17]. The reduction 
in the P peak may be due to extracellular leakage of small 
DNA fragments and nucleotides through defects created in 
the outer membranes of the cells undergoing apoptotic 
alterations. The stability of the S peak during programmed 
cell death might be explained by the fact that the sulphur- 
containing proteins are much larger than the fragmented 
DNA particles and, therefore, do not leak out of the cells 
and their levels remain unaltered intracellularly. In addi- 
tion, the X-ray spectra nalysis showed marked Ca influx 
into the dopamine-treated hymocytes (Fig. 2). Changes in 
the intracellular soluble Ca have been reported in associa- 
tion with apoptosis [16]. Our study is the first to report 
direct estimation of the alterations that occur in total 
(bound and free) cellular Ca during programmed cell 
death. 
Since cellular protein concentrations, represented by the 
S peak, were found to be relatively stable (Fig. 2); we have 
used this peak as an internal standard to follow spectra 
alterations. Comparison of K peaks in treated and un- 
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treated cells shows a significant correlation between cell 
viability and high intracellular levels of K. Treatment with 
low-dose dopamine (0.125 mM), dexamethasone or NaN 3 
show influx of K. In contrast, influx of P can be seen only 
in cells treated with 0.5 mM dopamine and dexametha- 
sone, while the levels of P in cells treated with NaN 3 have 
not changed. The low P levels found in cells treated with 
dopamine and dexamethasone ar  consistent with our other 
experiments showing DNA fragmentation. Therefore, these 
findings suggest that XRMA can be used as a very power- 
ful tool in the evaluation of cells undergoing apoptosis. 
We have recently shown that dopamine is also capable 
of inducing apoptosis in cultured chick sympathetic neu- 
rons [19] with features imilar to those observed following 
nerve growth factor (NGF) deprivation [20]. The mecha- 
nism through which dopamine sets in motion programmed 
cell death in thymocytes and sympathetic neurons is un- 
known. The responsible toxic agent may be dopamine 
itself and/or one or more of its metabolic by-products, 
such as semiquinones, quinones, neuromelanin and reac- 
tive oxygen radical species, e.g., H202. It was recently 
shown that free radicals may be involved in triggering 
programmed cell death [21]. Our observations that com- 
bined treatment with the antioxidant DTT prevented apop- 
tosis in thymocytes exposed to dopamine (Fig. 1). DTT 
can also inhibit the spontaneous, non-enzymatic conver- 
sion of dopamine to dark dopamine-neuromelanin i  cell- 
free culture media (Offen et al., in preparation). These 
observations suggest hat the apoptosis-inducing effect of 
dopamine shown in our experiments i mainly via its 
autooxidation metabolites. 
Since receptors for dopamine (but not the dopamine 
uptake machinery) are present on thymocytes, we cannot 
exclude the possibility that the observed opamine toxicity 
is receptor-mediated. However, we think that receptor 
involvement is not esser~tial. Dopamine receptors recog- 
nize and bind intact dopamine, while the toxicity, as 
mentioned above, is probably mediated through its oxida- 
tive metabolites. 
Based on the above, we propose that the anticancer 
effect of dopamine seen particularly in melanoma cells 
[22] may be due to induction of programmed cell death via 
a similar mechanism. 
There is a gradual decline in the number of substantia 
nigra dopaminergic neurons during normal aging [23]. The 
cause for this seemingly 'physiological' neuronal oss is 
unknown but it is not unl!ikely that it is due to activation of 
programmed cell death in 'selected' individual neurons. 
Since the first signs of Parkinson's disease emerge only 
after loss of about 70-80% of the dopaminergic neurons 
[24], the death of nigral cells during aging usually remains 
clinically silent. It is feasible that under normal circum- 
stances nigral neurons are equipped with adequate mecha- 
nisms (e.g., vesiculation of dopamine and naturally-occur- 
ring intracellular enzyme systems for the scavenging of 
excess free radicals) to restrain the potentially toxic effects 
of their own neurotransmitter, dopamine. However, it may 
be hypothesized that if in Parkinson's disease there is a yet 
unidentified failure of one or more of such defense mecha- 
nisms, enabling dopamine or its toxic products to gain 
access to the unprotected nucleus, programmed cell death 
may be triggered and the nigral neuron will self-destruct. 
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